VBI Vaccines Inc. (VBIVQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Inactive · Last trade price
on Jan 13, 2025
VBI Vaccines Revenue
VBI Vaccines had revenue of $1.21M in the quarter ending March 31, 2024, with 150.31% growth. This brings the company's revenue in the last twelve months to $9.41M, up 553.09% year-over-year. In the year 2023, VBI Vaccines had annual revenue of $8.68M with 702.40% growth.
Revenue (ttm)
9.41M
Revenue Growth
+553.09%
P/S Ratio
0.00
Revenue / Employee
69.71K
Employees
138
Market Cap
14.34K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8.68M | 7.60M | 702.40% |
| Dec 31, 2022 | 1.08M | 451.00K | 71.47% |
| Dec 31, 2021 | 631.00K | -430.00K | -40.53% |
| Dec 31, 2020 | 1.06M | -1.16M | -52.23% |
| Dec 31, 2019 | 2.22M | -1.13M | -33.80% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVBI Vaccines News
- 5 months ago - VBI Vaccines Issues Voluntary Nationwide Recall of all PreHevbrio Vaccine Due to Discontinuation of Company Operations - Financial Post
- 9 months ago - Dow Jumps Over 300 Points; US Trade Gap Narrows In June - Benzinga
- 9 months ago - VBI Vaccines provides restructuring proceedings update - Seeking Alpha